Herbalife Multivitamin (2019-11-20)
- Starting date:
- November 20, 2019
- Type of communication:
- Drug Recall
- Subcategory:
- Natural health products
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-71774
Last updated: 2019-12-02
Summary
- Product: Herbalife Multivitamin Tablets
Reason
The affected lots do not have childproof packaging. No mention on the label indicating that at least one child-resistant packaging format is available for this product.
Alternate Brand Names: F2 Multivitamin; Multivitamin
Depth of distribution
End users
Affected products
Herbalife Multivitamin Tablets
DIN, NPN, DIN-HIM
NPN 80085527Dosage form
Tablets
Strength
4-(1,3;1,4)-beta-D-Glucan 4-glucanohydrolase 0.75 FCC CU; 4-alpha-D-Glucan glucanohydrolase 5.5 FCC DU; Beta-carotene 900.0 mcg; Biotin 100.0 mcg; Calcium 146.0 mg; Chromium 33.0 mcg; Copper 0.5 mg; Folate 129.0 mcg; Inositol 2.0 mg; Iodine 46.0 mcg; Iron 2.0 mg; Lycopene 0.36 mg; Magnesium 66.7 mg; Manganese 1.6 mg; Niacinamide 33.3 mg; Potassium 10.0 mg; Protease 81.0 FCC HUT; Riboflavin 8.3 mg; Selenium 17.0 mcg; Thiamine 6.7 mg; Triacylglycerol lipase 2.2 FIP Lipase Units; Vanadium 2.0 mcg; Vitamin B12 1.0 mcg; Vitamin B6 10.0 mg; Vitamin C 43.0 mg; Vitamin D 2.65 mcg; Vitamin E 4.5 mg AT; Zinc 5.0 mg
Lot or serial number
229550A08, 229550B08
Companies
- Recalling Firm
-
Herbalife of Canada Ltd.
113-7075 Place Robert Joncas
Saint-Laurent
H4M 2Z2
Quebec
CANADA
- Marketing Authorization Holder
-
Herbalife International Luxembourg S.á R.L.
990 West 190th Street, Suite 650
Torrance
90502-1014
California
UNITED STATES